|
|
|
|
International Myositis Society - Newsletter 2/22
|
|
|
Upcoming papers on Myositis in press at our home journal "Clinical and Experimental Rheumatology - CER"
|
- The effect of COVID-19 pandemic on idiopathic inflammatory myositis patients: a single centre experiences
T. Béldi, A. Vincze, B. Miltényi-Szabo, Z. Varga, K. Szabo, Z. Griger, M. Nagy-Vincze
- Use of JAK inhibitors in dermatomyositis: a systematic literature review
J.J. Paik, G. Lubin, A. Gromatzky, P.N. Mudd, M.P. Ponda, L. Christopher-Stine
- Different clinical phenotypes in anti-melanoma differentiation-associated protein 5-associated positive dermatomyositis
P.A. Olivo Pallo, S.K. Shinjo
These myositis-related articles will appear at CER and can be found there in the press section.
|
|
|
|
The Global Conference on Myositis starts next week!
|
The 4th GCOM 2022 will be held in Prague, Czech Republic on 6 – 9 June 2022 at the O2 Universum multifunctional centre. The conference will be organized as a hybrid meeting, i.e. with in-person attendance as well as with virtual participation using simultaneous online streaming. All information at the GCOM Website
|
|
|
iMyoS - Meeting at the GCOM
|
The International Myositis Society - iMyoS - will have a meeting for all iMyoS members that participate at the GCOM in Prague. It will take place on Wednesday the 8th of June 2022 from 4:45 - 5:45 CET. Remote access is also possible for members that have registered for GCOM.
|
|
|
|
|
|
|
|
|